Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells

Journal of Membrane Biology

Volumn 234, Issue 1, 2010, Pages 47-56

  Faouzi, Malika ^a   Chopin, Valérie ^a   Ahidouch, Ahmed ^a,b   Ouadid Ahidouch, Halima ^a  

^a Université Picardie Jules Vernes   (France)

^b IBN ZOHR UNIVERSITY   (Morocco)

Author keywords

Breast adenocarcinoma; Cell proliferation; JAK2 pathway; K+ channel; MCF 7 cell; Prolactin

Indexed keywords

CALCIUM ION; CLOTRIMAZOLE; JANUS KINASE 2; JANUS KINASE INHIBITOR; JANUS KINASE INHIBITOR 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; POTASSIUM CHANNEL; PROLACTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALPHA CYANO (3,4 DIHYDROXY) N BENZYLCINNAMIDE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; CALCIUM; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN; PROLACTIN RECEPTOR; PYRAZOLE DERIVATIVE; TRAM 34; TYRPHOSTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL DENSITY; CELL PROLIFERATION; MEMBRANE CHANNEL; MEMBRANE STEADY POTENTIAL; PROTEIN PHOSPHORYLATION; BREAST TUMOR; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; CLOTRIMAZOLE; FEMALE; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; JANUS KINASE 2; PROLACTIN; PYRAZOLES; RECEPTORS, PROLACTIN; TYRPHOSTINS;

EID: 77949424378     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-010-9238-5     Document Type: Article

References (42)

1. Ali S, Pellegrini I, Kelly PA (1991) A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem 266:20110-20117
2. 2+-ATPase type 2. Biochem Biophys Res Commun 352:537-542
3. Biswas R, Vonderhaar BK (1987) Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res 47:3509-3514
4. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
5. Brockman JL, Schroeder MD, Schuler LA (2002) PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16:774-784
6. Clevenger CV, Plank TL (1997) Prolactin as an autocrine/paracrine factor in breast tissue. J Mammary Gland Biol Neoplasia 2:59-68
7. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/ paracrine loop. Am J Pathol 146:695-705
8. Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
9. Das R, Vonderhaar BK (1997) Prolactin as a mitogen in mammary cells. J Mammary Gland Biol Neoplasia 2:29-39
10. Ducret T, Boudina S, Sorin B, Vacher AM, Gourdou I, Liguoro D, Guerin J, Bresson-Bepoldin L, Vacher P (2002) Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells. Glia 38:200-214
11. Ducret T, Vacher AM, Vacher P (2004) Effects of prolactin on ionic membrane conductances in the human malignant astrocytoma cell line U87-MG. J Neurophysiol 91:1203-1216
12. Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S (2009) Re-evaluation of the prolactin receptor expression in human breast cancer. J Endocrinol 201:115-128
13. Gill S, Peston D, Vonderhaar BK, Shousha S (2001) Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol 54:956-960
14. Ginsburg E, Vonderhaar BK (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591-2595
15. Goffin V, Kinet S, Ferrag F, Binart N, Martial JA, Kelly PA (1996) Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. J Biol Chem 271:16573-16579
16. Goffin V, Bernichtein S, Touraine P, Kelly PA (2005) Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26:400-422
17. + channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. Histol Histopathol (in press)
18. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65:630-648
19. Liby K, Neltner B, Mohamet L, Menchen L, Ben-Jonathan N (2003) Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Res Treat 79:241-252
20. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V (2000) Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19:4695-4705
21. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79:202-211
22. + channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol 221:1-6
23. + channels in breast cancer cells. Biochem Biophys Res Commun 316:244-251
24. + channels in breast cancer cells: association with cell cycle progression. Am J Physiol 287:C125-C134
25. + channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471:157-164
26. Peirce SK, Chen WY (2001) Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 171:R1-R4
27. Prevarskaya N, Skryma R, Vacher P, Daniel N, Bignon C, Djiane J, Dufy B (1994) Early effects of PRL on ion conductances in CHO cells expressing PRL receptor. Am J Physiol 267:C554-C562
28. Prevarskaya NB, Skryma RN, Vacher P, Daniel N, Djiane J, Dufy B (1995) Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. J Biol Chem 270:24292-24299
29. 2+ channels in Chinese hamster ovary cells stably expressing prolactin receptor. J Mol Endocrinol 21:85-95
30. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV (1997) Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555-5560
31. Schroeder MD, Symowicz J, Schuler LA (2002) PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol Endocrinol 16:45-57
32. Sekine N, Ullrich S, Regazzi R, Pralong WF, Wollheim CB (1996) Postreceptor signaling of growth hormone and prolactin and their effects in the differentiated insulin-secreting cell line, INS-1. Endocrinology 137:1841-1850
33. Sorin B, Goupille O, Vacher AM, Paly J, Djiane J, Vacher P (1998) Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry. J Biol Chem 273:28461-28469
34. Swaminathan G, Varghese B, Thangavel C, Carbone CJ, Plotnikov A, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY (2008) Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol 196:R1-R7
35. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA (1998) Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 83:667-674
36. Tworoger SS, Hankinson SE (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 13:41-53
37. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814-6819
38. Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66:2476-2482
39. Vacher P, Tran Van ChuoiM, Paly J, Djiane J, DufyB(1994) Short term effect of prolactin on intracellular calcium in Chinese hamster ovary cells stably transfected with prolactin receptor complementary deoxyribonucleic acid. Endocrinology 134:1213-1218
40. + channel activation. Biochem J 377:569-578
41. Vonderhaar BK (1999) Prolactin involvement in breast cancer. Endocr Relat Cancer 6:389-404
42. + channels inhibits progression of human endometrial cancer. Oncogene 26:5107-5114